Madrigal Pharmaceuticals Inc (MDGL)
302.67
-12.48
(-3.96%)
USD |
NASDAQ |
Nov 14, 16:00
311.00
+8.33
(+2.75%)
Pre-Market: 08:20
Madrigal Pharmaceuticals Cash and Short Term Investments (Quarterly): 998.63M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 998.63M |
| June 30, 2024 | 1.058B |
| March 31, 2024 | 1.059B |
| December 31, 2023 | 634.13M |
| September 30, 2023 | 232.35M |
| June 30, 2023 | 298.42M |
| March 31, 2023 | 329.48M |
| December 31, 2022 | 358.77M |
| September 30, 2022 | 153.19M |
| June 30, 2022 | 211.77M |
| March 31, 2022 | 219.95M |
| December 31, 2021 | 270.35M |
| September 30, 2021 | 299.14M |
| June 30, 2021 | 323.85M |
| March 31, 2021 | 307.22M |
| December 31, 2020 | 284.15M |
| September 30, 2020 | 335.94M |
| June 30, 2020 | 384.38M |
| March 31, 2020 | 408.51M |
| December 31, 2019 | 439.04M |
| September 30, 2019 | 453.61M |
| June 30, 2019 | 466.40M |
| March 31, 2019 | 477.82M |
| December 31, 2018 | 483.72M |
| September 30, 2018 | 488.54M |
| Date | Value |
|---|---|
| June 30, 2018 | 490.30M |
| March 31, 2018 | 182.82M |
| December 31, 2017 | 191.53M |
| September 30, 2017 | 62.14M |
| June 30, 2017 | 67.17M |
| March 31, 2017 | 40.13M |
| December 31, 2016 | 40.50M |
| September 30, 2016 | 39.56M |
| June 30, 2016 | 43.02M |
| March 31, 2016 | 52.04M |
| December 31, 2015 | 0.3062M |
| September 30, 2015 | 88.25M |
| June 30, 2015 | 98.33M |
| March 31, 2015 | 76.61M |
| December 31, 2014 | 97.69M |
| September 30, 2014 | 119.28M |
| June 30, 2014 | 112.06M |
| March 31, 2014 | 78.79M |
| December 31, 2013 | 91.48M |
| September 30, 2013 | 53.38M |
| June 30, 2013 | 70.20M |
| March 31, 2013 | 90.39M |
| December 31, 2012 | 100.60M |
| September 30, 2012 | 55.14M |
| June 30, 2012 | 44.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
153.19M
Minimum
Sep 2022
1.059B
Maximum
Mar 2024
430.31M
Average
326.66M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ADMA Biologics Inc | 86.71M |
| 89bio Inc | 423.77M |
| Corcept Therapeutics Inc | 380.34M |
| Sarepta Therapeutics Inc | 1.198B |
| Matinas BioPharma Holdings Inc | 14.31M |